ENGAGE run · 52ee95bb19a4

```json [ { "post_index": 15, "cluster_ids": [9, 21], "claim": "Anthropic AI for Science accelerates generative AI drug discovery pipelines", "argument_type": "empirical_claim", "stance": "supports_status_quo", "hyde_excerpt": "Anthropic's AI for Science program is enabling vaccine and therapeutic developers to compress drug discovery timelines by automating molecular des

```json [ { "post_index": 12, "cluster_ids": [7, 16], "claim": "GLP-1 drugs linked to sudden blindness with 4-7x increased risk", "argument_type": "empirical_claim", "stance": "challenges_status_quo", "hyde_excerpt": "Recent observational data suggest a potential association between GLP-1 receptor agonist use and sudden vision loss, with some studies reporting a 4-7 fold

```json [] ```

```json [ { "post_index": 6, "matched_article_id": 616, "match_confidence": 82, "match_reason": "Tweet claims Lilly is fighting to reclassify retatrutide as a biologic to block compounding and secure exclusivity — the article analyzes retatrutide's TRIUMPH-1 data and its implications for the Lilly competitive position, payer repricing, and the compounding/biosimilar market dynami

[]

```json [] ```